Tüm alıştırma soruları

4736 soru

Soru 3221Soru →

Match each clinical presentation with the single most appropriate evidence-based screening, immunization, or preventive intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old man with no chronic medical conditions and no family history of malignancy
A 67-year-old man who smoked cigarettes for 15 years but quit smoking at age 35
A 65-year-old woman with no chronic medical conditions who last received a tetanus booster 5 years ago
A 38-year-old woman with a body mass index of 33 kg/m² and normal blood pressure

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 45-year-old man requires colorectal cancer screening; the 67-year-old former smoker requires abdominal aortic aneurysm screening; the 65-year-old woman requires pneumococcal vaccination; and the 38-year-old woman with obesity requires diabetes screening.
Appropriate preventive care requires matching patient-specific demographic factors—such as age, sex, BMI, and smoking history—with current USPSTF and ACIP guidelines. Colorectal screening universally begins at age 45. AAA screening applies to men 65-75 with any smoking history. Pneumococcal vaccines are universally indicated at age 65. Diabetes screening is indicated for overweight and obese adults starting at age 35.

Adım Adım Çözüm

1
Analyze the 45-year-old man's risk profile (average risk, age 45).
Matched to colorectal cancer screening.
Current USPSTF guidelines recommend lowering the initiation age for colorectal cancer screening to 45 years due to the rising incidence of early-onset disease.
2
Analyze the 67-year-old man's risk profile (age 65-75, any lifetime history of smoking).
Matched to one-time abdominal aortic aneurysm screening with ultrasound.
Any smoking history (≥100 cigarettes) triggers the indication for AAA screening in men reaching age 65, regardless of when they quit.
3
Analyze the 65-year-old woman's risk profile (age 65).
Matched to administration of a pneumococcal conjugate vaccine.
Age 65 is the universal threshold for initiating routine adult pneumococcal vaccination for individuals without high-risk immunocompromising conditions.
4
Analyze the 38-year-old woman's risk profile (age 35-70, BMI > 25 kg/m²).
Matched to hemoglobin A1c or fasting plasma glucose test.
USPSTF guidelines mandate type 2 diabetes screening for adults aged 35 to 70 who present with overweight or obesity.

Anahtar Kavram

Application of age- and risk-based USPSTF and ACIP preventive care guidelines across diverse adult populations.
Soru 3222Soru →

A 54-year-old man who underwent an orthotopic heart transplant six months ago is admitted to the hospital with hemoptysis, pleuritic chest pain, and a low-grade fever. His maintenance immunosuppressive regimen consists of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Chest computed tomography reveals a right upper lobe dense consolidation with a surrounding halo of ground-glass opacity. Serum galactomannan testing is markedly positive, establishing a diagnosis of invasive pulmonary aspergillosis. The infectious disease service recommends initiating intravenous posaconazole therapy immediately.

Which of the following treatment modifications and monitoring strategies are indicated for this patient upon starting the antifungal therapy? (Select two)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Decrease the daily dose of tacrolimus empirically.; Perform serial electrocardiograms to monitor the QTc interval.

Cevap

The correct strategies are to decrease the daily dose of tacrolimus empirically and to perform serial electrocardiograms to monitor the QTc interval.
Posaconazole is a potent inhibitor of the cytochrome P450 3A4 (CYP3A4) enzyme. Tacrolimus is a calcineurin inhibitor that is heavily metabolized by CYP3A4. Coadministration leads to significantly elevated tacrolimus levels, greatly increasing the risk of acute nephrotoxicity and neurotoxicity. Standard of care requires a preemptive, empiric reduction in the tacrolimus dose (often by one-third to one-half) when starting an azole antifungal. Furthermore, both posaconazole and tacrolimus are known to cause QTc interval prolongation. Their concomitant use creates an additive risk for malignant arrhythmias, mandating serial electrocardiogram (ECG) monitoring.

Adım Adım Çözüm

1
Evaluate the proposed new medication (posaconazole) for pharmacokinetic interactions with the patient's current immunosuppressive regimen.
Posaconazole is identified as a strong inhibitor of the CYP3A4 enzyme, which is responsible for the metabolism of tacrolimus.
Preventing acute calcineurin inhibitor toxicity (such as severe nephrotoxicity and neurotoxicity) requires anticipating impaired clearance of the drug.
2
Assess for overlapping or additive toxicities between the patient's current medications and posaconazole.
Both tacrolimus and posaconazole are recognized as medications that can independently prolong the QTc interval.
Recognizing additive adverse effect profiles is crucial to prevent life-threatening arrhythmias, such as Torsades de Pointes.
3
Implement a safe initiation and monitoring strategy.
Empirically reduce the tacrolimus dose, start posaconazole without delay, and order serial ECGs for the duration of concurrent therapy.
This comprehensively balances the need for life-saving antifungal therapy with the severe risks of immunosuppressant toxicity and malignant arrhythmias.

Anahtar Kavram

Management of pharmacokinetic interactions and overlapping toxicities when initiating azole antifungals in solid organ transplant recipients.
Tahmini Süre:2m 0s
Soru 3223Soru →

A 28-year-old woman is brought to the emergency department by paramedics after experiencing sudden-onset, severe lower abdominal pain and a syncopal episode at home. She reports that her last menstrual period was 7 weeks ago. Her past medical history is significant for a lifelong tendency to bruise easily, frequent epistaxis, and heavy menstrual bleeding. For her bleeding issues, she occasionally uses a specific nasal spray prescribed by her hematologist.

Vital signs on arrival are: temperature 37.0°C (98.6°F), blood pressure 85/50 mmHg, heart rate 128/min, and respiratory rate 22/min. Physical examination reveals a pale, diaphoretic patient with a distended abdomen exhibiting diffuse tenderness, guarding, and rebound tenderness.

Laboratory studies are as follows:

TestResultReference Range
Hemoglobin7.2 g/dL12.0-15.5 g/dL
Platelet count250,000/µL150,000-400,000/µL
Prothrombin time (PT)12 sec11-14 sec
Activated partial thromboplastin time (aPTT)46 sec25-35 sec
Serum beta-hCG4,500 mIU/mL< 5 mIU/mL (non-pregnant)

The patient is urgently prepped for surgery for a presumed ruptured ectopic pregnancy. In addition to addressing the acute hemorrhage, the surgical team must formulate a care plan for her underlying bleeding diathesis. Which of the following conditions most likely accounts for this patient's underlying hematologic abnormality?

Cevabı ve açıklamayı göster

Cevap: Von Willebrand disease

Cevap

Von Willebrand disease
The correct diagnosis is von Willebrand disease (vWD). This patient's presentation of lifelong mucocutaneous bleeding (epistaxis, menorrhagia) strongly suggests a primary hemostasis defect. However, her platelet count is normal, and she exhibits an isolated prolongation of the activated partial thromboplastin time (aPTT). Von Willebrand factor (vWF) serves two crucial roles: it bridges platelets to exposed subendothelial collagen (primary hemostasis) and acts as a protective carrier protein for Factor VIII (secondary hemostasis). A deficiency in vWF leads to mucosal bleeding and increased clearance of Factor VIII, resulting in a prolonged aPTT. Furthermore, the history of using a hematologist-prescribed nasal spray strongly suggests desmopressin (DDAVP), which induces the rapid release of stored vWF and Factor VIII from endothelial Weibel-Palade bodies, providing effective temporary hemostasis for patients with mild to moderate vWD.

Adım Adım Çözüm

1
Analyze the acute clinical presentation.
The patient has a ruptured ectopic pregnancy causing acute intra-abdominal hemorrhage and hypovolemic shock (hypotension, tachycardia, low hemoglobin).
To understand the immediate life-threatening condition requiring surgical intervention.
2
Evaluate the chronic history and hematologic laboratory values.
The patient has a lifelong history of mucosal bleeding (epistaxis, heavy menses), normal platelet count, normal PT, and an isolated prolonged aPTT.
To formulate a differential diagnosis for her underlying bleeding diathesis that requires ongoing management during and after surgery.
3
Incorporate the pharmacologic clue.
The patient uses a hematologist-prescribed nasal spray for bleeding, which is characteristic of desmopressin (DDAVP).
DDAVP nasal spray is a standard treatment for mild hemophilia A and von Willebrand disease, as it induces the release of stored vWF and Factor VIII from endothelial cells.
4
Synthesize the findings to identify the most likely underlying condition.
Mucosal bleeding + normal platelets + prolonged aPTT + response to DDAVP = von Willebrand disease.
Von Willebrand factor is necessary for platelet adhesion (preventing mucosal bleeding) and stabilizes Factor VIII (deficiency leads to prolonged aPTT). DDAVP treats both defects simultaneously.

Anahtar Kavram

Von Willebrand disease presents with mucosal bleeding, a normal platelet count, and a normal or prolonged aPTT (due to concurrent Factor VIII reduction). It is effectively treated with desmopressin (DDAVP).
Tahmini Süre:1m 15s
Soru 3224Soru →

An asymptomatic 37-year-old man presents to the outpatient clinic to establish primary care. He feels well and reports no fatigue, polyuria, or changes in vision. His medical history is unremarkable, and he takes no prescription medications. He works as a software engineer and describes his lifestyle as sedentary. He does not smoke or use illicit drugs and consumes alcohol socially. His father was diagnosed with type 2 diabetes mellitus at age 50.

Records indicate he had a normal fasting lipid panel at age 32 and a negative hepatitis C antibody test three years ago.

Vital signs show a blood pressure of 126/80 mm Hg and a heart rate of 72/min. His body mass index is 29 kg/m^2. Physical examination is unremarkable, with no acanthosis nigricans or peripheral edema.

In accordance with current preventive care guidelines, which of the following is the most appropriate screening test to perform today?

Cevabı ve açıklamayı göster

Cevap: Hemoglobin A1c

Cevap

Hemoglobin A1c testing should be performed because the patient is between the ages of 35 and 70 and has a BMI classified as overweight, which meets the current USPSTF criteria for diabetes screening.
This patient is a 37-year-old man with a BMI of 29 kg/m^2, which classifies him as overweight. According to the United States Preventive Services Task Force (USPSTF) guidelines (updated in 2021), clinicians should screen for prediabetes and type 2 diabetes in adults aged 35 to 70 years who are overweight or obese. Hemoglobin A1c, fasting plasma glucose, or an oral glucose tolerance test are all acceptable screening modalities. Given his age and BMI, screening is strongly indicated to identify early dysglycemia and initiate appropriate lifestyle or pharmacologic interventions. His family history of diabetes further compounds his risk, though his age and BMI alone are sufficient to trigger the recommendation.

Adım Adım Çözüm

1
Analyze the patient's demographic and clinical risk profile.
The patient is a 37-year-old male with a BMI of 29 kg/m^2, indicating he is overweight.
Identifying age and BMI is critical for accurately applying metabolic screening guidelines.
2
Evaluate the need for type 2 diabetes screening.
The patient qualifies for diabetes screening because he falls within the 35 to 70 age range and has a BMI >= 25 kg/m^2.
The USPSTF recently updated its guidelines to lower the starting age for diabetes screening from 40 to 35 for overweight and obese adults.
3
Rule out other routine screening modalities based on age and lack of symptoms.
Tests such as FIT, TSH, urinalysis, and ECG do not meet the criteria for routine screening in this asymptomatic 37-year-old.
Adhering to evidence-based guidelines prevents overdiagnosis, unnecessary healthcare costs, and potential harms from false positives.

Anahtar Kavram

The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 years who are overweight or obese.
Soru 3225Soru →

A 70-year-old man presents to the preoperative clinic for evaluation prior to an elective right total hip arthroplasty for severe osteoarthritis. His medical history is significant for hypertension, hyperlipidemia, and a non-ST-segment elevation myocardial infarction (NSTEMI) that occurred 6 weeks ago. At that time, he underwent percutaneous coronary intervention with the placement of a drug-eluting stent (DES) in the left anterior descending artery. His current medications include aspirin, clopidogrel, metoprolol, lisinopril, and atorvastatin. He reports no chest pain or shortness of breath with his current limited daily activities. Vital signs are within normal limits. Physical examination is unremarkable except for decreased range of motion and crepitus in the right hip. Which of the following are the most appropriate recommendations regarding his surgical and perioperative management? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Postpone the elective arthroplasty until at least 6 months have passed since the stent placement; When the surgery is eventually performed, continue aspirin therapy throughout the perioperative period

Cevap

The most appropriate recommendations are to postpone the elective surgery for at least 6 months after the stent placement and to continue aspirin therapy perioperatively when the procedure is eventually performed.
Patients who undergo percutaneous coronary intervention with a drug-eluting stent require dual antiplatelet therapy (DAPT) to prevent stent thrombosis. For patients with acute coronary syndrome, DAPT is typically indicated for 12 months. Current guidelines mandate that elective noncardiac surgery be delayed for at least 6 months after DES placement to allow for adequate endothelialization of the stent. Furthermore, when elective surgery is eventually performed, aspirin should be continued perioperatively to maintain baseline platelet inhibition, as the risk of cardiac events generally outweighs the risk of surgical bleeding.

Adım Adım Çözüm

1
Evaluate the urgency of the proposed surgical intervention.
The procedure is an elective total hip arthroplasty.
Elective surgeries offer flexibility in scheduling, allowing optimization of the patient's cardiovascular status prior to the procedure.
2
Assess the patient's recent cardiovascular history and interventions.
The patient had a drug-eluting stent (DES) placed 6 weeks ago for a non-ST-segment elevation myocardial infarction.
Recent acute coronary syndrome and DES placement are major risk factors for perioperative myocardial infarction and stent thrombosis.
3
Apply surgical timing guidelines for patients with recent DES placement.
Elective noncardiac surgery should be postponed for at least 6 months (and optimally 12 months following acute coronary syndrome).
Performing surgery shortly after stent placement requires premature cessation of dual antiplatelet therapy and induces a prothrombotic state, significantly increasing the risk of stent thrombosis.
4
Determine the optimal perioperative antiplatelet strategy when surgery is eventually performed.
Aspirin should be continued throughout the perioperative period.
Maintaining single antiplatelet therapy reduces the risk of adverse cardiac events without prohibitively increasing the risk of major surgical bleeding.

Anahtar Kavram

Perioperative cardiovascular management and timing of elective noncardiac surgery following drug-eluting stent placement.
Tahmini Süre:1m 30s
Soru 3226Soru →

A 66-year-old man is evaluated for discharge on hospital day 12. He was admitted for a severe acute exacerbation of chronic obstructive pulmonary disease (COPD) requiring intubation and mechanical ventilation. He was successfully extubated three days ago and is currently stable on 2 L/min of oxygen via nasal cannula. He is hemodynamically stable, afebrile, and his acute respiratory infection has resolved. His comorbidities include heart failure with preserved ejection fraction and type 2 diabetes mellitus. During his intensive care unit stay, he developed a new Stage 3 pressure injury on his sacrum that requires daily skilled wound care. Prior to admission, he was fully ambulatory and independent. Currently, he requires moderate assistance with all transfers and can walk only 15 feet with a walker before becoming severely dyspneic and fatigued. A physical therapy evaluation concludes that he has significant rehabilitation potential but can currently tolerate a total of only 60 to 90 minutes of therapy spread throughout the day due to cardiopulmonary limitations. Laboratory studies show a stable serum creatinine of 1.4 mg/dL (baseline 1.3 mg/dL). He lives with his elderly wife, who has severe osteoarthritis and uses a wheelchair, rendering her unable to assist him with mobility or personal care.

Which of the following is the most appropriate disposition plan for this patient?

Cevabı ve açıklamayı göster

Cevap: Transfer to a skilled nursing facility

Cevap

Transfer to a skilled nursing facility
The correct disposition is transfer to a skilled nursing facility (SNF). This patient is medically stable and ready for discharge from the acute care hospital, but he has two significant ongoing needs: daily skilled wound care for a Stage 3 pressure injury and multidiciplinary rehabilitation for severe deconditioning. Because he can only tolerate 60 to 90 minutes of therapy daily, he does not qualify for an inpatient rehabilitation facility (IRF), which strictly requires the ability to participate in at least 3 hours of intensive therapy per day. Furthermore, discharging him home with home health services is unsafe; home health agencies provide intermittent skilled visits, but the patient requires ongoing custodial assistance for transfers and ADLs that his wheelchair-bound wife cannot provide. An SNF provides the appropriate combination of 24-hour custodial care, skilled nursing for wound management, and rehabilitation paced to the patient's tolerance.

Adım Adım Çözüm

1
Determine the patient's medical stability for discharge.
The patient is extubated, hemodynamically stable, afebrile, and his infection has resolved.
Establishing medical stability confirms the patient no longer requires acute inpatient hospital care and is ready for post-acute disposition.
2
Assess the patient's functional status, skilled care needs, and therapy tolerance.
The patient requires daily skilled wound care for a Stage 3 pressure injury and physical therapy, but can only tolerate 60 to 90 minutes of therapy per day.
Specific post-acute care facilities have strict admission criteria based on therapy tolerance and medical needs.
3
Evaluate the safety and feasibility of a home discharge.
Home discharge is deemed unsafe because the patient requires moderate assistance with transfers and his wife is physically unable to assist him.
Home health services only provide intermittent care; 24-hour safety and custodial support must be available from family for a safe home discharge in a highly dependent patient.
4
Select the appropriate care setting based on the synthesized criteria.
A skilled nursing facility (SNF) is selected.
SNFs accommodate patients who need daily skilled nursing and therapy but cannot meet the 3-hour daily intensive therapy requirement of an inpatient rehabilitation facility (IRF).

Anahtar Kavram

Appropriate disposition for post-acute care requires matching the patient's medical stability, physical therapy tolerance (e.g., 3-hour minimum for IRF), skilled nursing needs, and available home caregiver support to strict facility criteria.
Soru 3227Soru →

A 5858-year-old man is admitted to the hospital with a 22-day history of diffuse abdominal pain, fever, and confusion. He has a history of decompensated alcohol-associated cirrhosis. His current medications include furosemide, spironolactone, and nadolol. Temperature is 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}), blood pressure is 96/60 mm Hg96/60\text{ mm Hg}, pulse is 102/min102/\text{min}, and respirations are 18/min18/\text{min}. Physical examination reveals scleral icterus, spider angiomata, and a distended, diffusely tender abdomen with shifting dullness. Mild asterixis is present.

Laboratory results:
Hemoglobin: 10.2 g/dL10.2\text{ g/dL}
Platelet count: 88,000/mm388,000/\text{mm}^3
Leukocyte count: 11,500/mm311,500/\text{mm}^3
Blood urea nitrogen: 36 mg/dL36\text{ mg/dL}
Serum creatinine: 1.8 mg/dL1.8\text{ mg/dL} (baseline 1.0 mg/dL1.0\text{ mg/dL})
Total bilirubin: 3.4 mg/dL3.4\text{ mg/dL}
INR: 1.71.7

Diagnostic paracentesis yields cloudy ascitic fluid with a polymorphonuclear leukocyte count of 650/mm3650/\text{mm}^3. Intravenous cefotaxime is initiated, and his home medications are temporarily withheld. Which of the following is the most appropriate additional pharmacologic intervention at this time?

Cevabı ve açıklamayı göster

Cevap: Intravenous albumin

Cevap

Intravenous albumin
The correct answer is intravenous albumin. This patient has spontaneous bacterial peritonitis (SBP), diagnosed by an ascitic fluid PMN count >250/mm3>250/\text{mm}^3. While empiric antibiotic therapy (e.g., third-generation cephalosporin like cefotaxime) is the crucial first step, patients with SBP are at significant risk for developing hepatorenal syndrome (HRS) due to systemic vasodilation and reduced effective arterial blood volume. The risk of HRS and mortality is highest in patients with preexisting or concurrent renal dysfunction. Guidelines strictly recommend the administration of intravenous albumin (1.5 g/kg1.5\text{ g/kg} on day 1, and 1.0 g/kg1.0\text{ g/kg} on day 3) for SBP patients who meet any of the following criteria: serum creatinine >1.0 mg/dL>1.0\text{ mg/dL}, blood urea nitrogen >30 mg/dL>30\text{ mg/dL}, or total bilirubin >4.0 mg/dL>4.0\text{ mg/dL}. This patient meets the criteria with a creatinine of 1.8 mg/dL1.8\text{ mg/dL} and BUN of 36 mg/dL36\text{ mg/dL}. Albumin provides prolonged oncotic support, improving renal perfusion and significantly reducing the incidence of HRS and short-term mortality.

Adım Adım Çözüm

1
Diagnose the acute condition based on clinical presentation and ascitic fluid analysis.
The patient has spontaneous bacterial peritonitis (SBP), confirmed by an ascitic fluid polymorphonuclear leukocyte (PMN) count >250/mm3>250/\text{mm}^3.
Accurate diagnosis is required to initiate the correct standard-of-care protocol.
2
Assess the patient's renal function and hemodynamic status.
The patient has acute kidney injury (AKI) with a serum creatinine of 1.8 mg/dL1.8\text{ mg/dL} (baseline 1.0 mg/dL1.0\text{ mg/dL}), an elevated BUN of 36 mg/dL36\text{ mg/dL}, and borderline hypotension.
Renal impairment in the setting of SBP places the patient at high risk for developing hepatorenal syndrome (HRS).
3
Determine the necessary pharmacologic interventions beyond empiric antibiotics.
In addition to cefotaxime, the administration of intravenous albumin is indicated.
Guidelines recommend IV albumin for SBP patients with Cr >1.0 mg/dL>1.0\text{ mg/dL}, BUN >30 mg/dL>30\text{ mg/dL}, or total bilirubin >4.0 mg/dL>4.0\text{ mg/dL} to expand effective circulating volume and prevent HRS.

Anahtar Kavram

Patients with spontaneous bacterial peritonitis (SBP) who have concurrent renal dysfunction (creatinine >1.0 mg/dL>1.0\text{ mg/dL} or BUN >30 mg/dL>30\text{ mg/dL}) require intravenous albumin supplementation in addition to antibiotics to prevent hepatorenal syndrome and reduce mortality.
Soru 3228Soru →

A 78-year-old woman is evaluated in the intensive care unit for new-onset fever and abdominal pain. She was admitted 5 days ago for a massive anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock. She currently remains on a dobutamine infusion for hemodynamic support. Over the past 12 hours, her temperature has risen to 39.2°C (102.6°F) and she has developed significant right upper quadrant abdominal tenderness. Her blood pressure is 88/56 mm Hg and pulse is 115/min. Laboratory studies show a leukocyte count of 18,500/mm³ with a left shift. Liver function tests reveal normal total bilirubin and alkaline phosphatase levels. A bedside right upper quadrant ultrasound demonstrates gallbladder wall thickening of 6 mm, pericholecystic fluid, and a positive sonographic Murphy sign. No gallstones or common bile duct dilation are visualized. Intravenous broad-spectrum antibiotics are initiated. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Percutaneous cholecystostomy tube placement

Cevap

Percutaneous cholecystostomy tube placement is the most appropriate next step for this critically ill patient with acute acalculous cholecystitis.
The correct intervention is percutaneous cholecystostomy tube placement. This patient has developed acute acalculous cholecystitis (AAC), a severe inflammation of the gallbladder without gallstones that typically occurs in critically ill, hospitalized patients (e.g., those with recent surgery, trauma, burns, or prolonged shock). The diagnosis is confirmed clinically by fever, leukocytosis, and right upper quadrant pain, combined with ultrasound findings of gallbladder wall thickening and pericholecystic fluid. Source control is mandatory because AAC progresses rapidly to gallbladder gangrene and perforation. While laparoscopic cholecystectomy is the definitive treatment for acute cholecystitis, this patient is in cardiogenic shock on dobutamine following a massive myocardial infarction, making her a prohibitively high surgical risk. Percutaneous cholecystostomy provides rapid, minimally invasive biliary decompression and source control without the need for general anesthesia.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and ultrasound findings.
The patient has fever, leukocytosis, right upper quadrant pain, and ultrasound findings of gallbladder inflammation without stones, confirming the diagnosis of acute acalculous cholecystitis.
Establishing the correct diagnosis is the first step in determining appropriate management.
2
Assess the patient's surgical risk.
The patient is recovering from a massive myocardial infarction and is in active cardiogenic shock requiring dobutamine.
Surgical risk stratification determines whether a patient can safely undergo a definitive surgical procedure like a cholecystectomy.
3
Determine the appropriate intervention based on surgical risk.
Because the surgical risk is prohibitively high, a minimally invasive percutaneous drainage procedure must be selected to achieve necessary source control.
Untreated acalculous cholecystitis is rapidly fatal due to gangrene and perforation; if surgery is contraindicated, percutaneous cholecystostomy is the standard of care.

Anahtar Kavram

Acute acalculous cholecystitis typically occurs in critically ill patients (e.g., sepsis, trauma, cardiogenic shock). Because these patients are usually poor surgical candidates, the treatment of choice is antibiotics and percutaneous cholecystostomy.
Tahmini Süre:1m 15s
Soru 3229Soru →

A 45-year-old man is evaluated by the multidisciplinary care team for discharge planning on hospital day 12. He was originally admitted after sustaining a traumatic brain injury and multiple rib fractures in a motor vehicle collision. His hospital course was initially complicated by a brief period of mechanical ventilation, but he was extubated on day 4 and is currently medically stable. Vital signs are within normal limits. On physical examination, the patient is alert and oriented to person, place, and time. He has residual right-sided hemiparesis, with motor strength of 3/5 in the right upper and lower extremities. His swallowing function is intact. A physical therapy evaluation demonstrates that he requires moderate assistance with bed-to-chair transfers and ambulation. The patient is highly motivated and successfully participated in a combined total of 3.5 hours of physical, occupational, and speech therapy yesterday without excessive fatigue. His wife is supportive and plans to take a leave of absence from work to assist him, but they live in a two-story home with bedrooms on the second floor. Which of the following is the most appropriate disposition for this patient?

Cevabı ve açıklamayı göster

Cevap: Inpatient rehabilitation facility

Cevap

Inpatient rehabilitation facility
The correct disposition is an inpatient rehabilitation facility (IRF). IRFs are designed for medically stable patients who require intensive, multidisciplinary rehabilitation (such as physical, occupational, and speech therapy) and can tolerate at least 3 hours of therapy per day. This patient has significant functional deficits due to his traumatic brain injury but is highly motivated and has explicitly demonstrated the ability to participate in 3.5 hours of therapy without excessive fatigue.

Adım Adım Çözüm

1
Assess the patient's medical stability and current acuity.
The patient is medically stable, extubated, and has normal vital signs, ruling out the need for continued acute care or long-term acute care (LTACH).
Determining medical stability is the crucial first step in care transition planning.
2
Evaluate the patient's functional status, safety, and therapy needs.
The patient has significant neurological deficits (hemiparesis), requires moderate assistance with transfers, and lives in a two-story home, making an immediate transition to home unsafe.
Ensuring a safe discharge environment prevents readmissions and patient harm.
3
Determine the appropriate level of post-acute rehabilitation based on therapy tolerance.
The patient successfully participated in 3.5 hours of multidisciplinary therapy, indicating he can tolerate the rigorous requirements of an inpatient rehabilitation facility (IRF).
Matching the patient's functional capacity and therapy tolerance to the correct facility level ensures optimal recovery.

Anahtar Kavram

Appropriate disposition for post-acute rehabilitation depends heavily on the patient's medical stability and ability to tolerate intensive therapy (at least 3 hours per day for an IRF versus less intensive therapy in a SNF).
Soru 3230Soru →

A 78-year-old man is being prepared for discharge after a 12-day hospitalization for urosepsis. Upon admission, his temperature was 38.9°C (102.0°F), blood pressure was 85/50 mm Hg, and serum creatinine was 3.2 mg/dL. He responded well to intravenous fluids and antibiotics; current vitals are temperature 37.1°C (98.8°F), blood pressure 122/76 mm Hg, and heart rate 78/min. His serum creatinine has improved to 1.8 mg/dL. Despite medical stabilization, his functional status has declined, requiring the assistance of two people for transfers. Furthermore, his cognitive status continues to fluctuate with new-onset delirium, and a formal assessment reveals he currently lacks medical decision-making capacity. The care team is initiating the discharge process. Arrange the following critical steps in this patient's transition of care in the most appropriate chronological order to ensure a safe, legally sound, and comprehensive disposition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Identify the surrogate decision-maker, 2) Determine the post-acute care setting, 3) Perform medication reconciliation, 4) Finalize the discharge summary, and 5) Execute a verbal provider-to-provider handoff.
A safe and legally sound transition of care for an incapacitated patient follows a structured sequence: First, the legally authorized surrogate must be identified to provide consent. Second, the appropriate care setting is determined collaboratively with the surrogate. Third, medication reconciliation is performed to tailor the pharmacologic plan to the patient's current physiologic state and the new setting. Fourth, these plans are formalized into a comprehensive written discharge summary. Finally, a synchronous verbal handoff is conducted to ensure closed-loop communication with the receiving providers.

Adım Adım Çözüm

1
Assess the patient's capacity and legal framework.
Identification of the surrogate decision-maker.
The patient's delirium impairs capacity, meaning legal consent for discharge planning must come from the authorized surrogate.
2
Collaborate on disposition planning.
Determination of the post-acute care setting.
The surrogate and multidisciplinary team must agree on the discharge location based on the patient's severe functional decline.
3
Optimize medical therapy for discharge.
Comprehensive medication reconciliation.
Medications must be adjusted for the patient's improving but still impaired renal function and the formulary capabilities of the receiving setting before finalizing discharge orders.
4
Document the transition plan.
Finalization of the discharge summary.
A comprehensive written document detailing the hospital course, reconciled medications, and pending tests is essential for continuity of care.
5
Communicate the plan to the receiving team.
Synchronous verbal handoff.
Direct communication resolves ambiguities and ensures the receiving facility is fully prepared for the transfer.

Anahtar Kavram

Standardized transition of care protocol for incapacitated patients
Tahmini Süre:1m 30s
Soru 3231Soru →

A 3434-year-old female is evaluated in the emergency department after experiencing the abrupt onset of severe, cramping periumbilical pain radiating to her back 66 hours ago. She has also had multiple episodes of bilious vomiting. Her medical history is significant for morbid obesity, for which she underwent an uncomplicated laparoscopic Roux-en-Y gastric bypass 44 years ago. Her current body mass index is 26 kg/m226 \text{ kg/m}^2. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 112/68 mm Hg112/68 \text{ mm Hg}, pulse is 118/min118/\text{min}, and respirations are 20/min20/\text{min}. Physical examination reveals a non-distended but diffusely tender abdomen, particularly in the periumbilical region, with mild voluntary guarding. Bowel sounds are high-pitched and hyperactive. Laboratory studies show a leukocyte count of 14,200/mm314,200/\text{mm}^3 and a serum lactate level of 3.1 mmol/L3.1 \text{ mmol/L}. A computed tomography scan of the abdomen and pelvis with intravenous contrast reveals small bowel dilation with a transition point and a 'swirl sign' of the mesenteric vessels. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Emergent surgical exploration

Cevap

Emergent surgical exploration
The correct answer is emergent surgical exploration. This patient is presenting with a small bowel obstruction complicated by suspected bowel ischemia (indicated by tachycardia, leukocytosis, and an elevated serum lactate), most likely due to an internal hernia. Patients with a history of Roux-en-Y gastric bypass are at high risk for internal hernias because the surgical restructuring creates unnatural mesenteric defects (e.g., Petersen's space, mesojejunal defect) through which the small bowel can herniate. The 'swirl sign' on computed tomography imaging represents twisted mesenteric vessels and is a highly specific indicator of an internal hernia with a closed-loop obstruction. Because closed-loop obstructions rapidly progress to strangulation, irreversible ischemia, and necrosis, immediate operative intervention (diagnostic laparoscopy or exploratory laparotomy) is absolutely necessary to reduce the herniated bowel, assess its viability, and close the mesenteric defects.

Adım Adım Çözüm

1
Evaluate the patient's history and acute presentation.
The patient has a history of Roux-en-Y gastric bypass and presents with severe abdominal pain, bilious vomiting, tachycardia, leukocytosis, and elevated lactate.
These findings are highly suspicious for a surgical abdomen, particularly bowel ischemia.
2
Interpret the imaging findings in the context of her surgical history.
The CT scan shows a 'swirl sign' of the mesenteric vessels and a small bowel transition point, confirming a closed-loop obstruction due to an internal hernia.
Roux-en-Y gastric bypass creates mesenteric defects that predispose patients to internal hernias, which often present as closed-loop obstructions.
3
Determine the appropriate intervention.
The patient requires emergent surgical exploration.
Closed-loop obstructions with signs of ischemia (elevated lactate, leukocytosis) carry a high mortality rate if definitive surgical reduction is delayed.

Anahtar Kavram

Recognition and immediate surgical management of an internal hernia presenting as a closed-loop obstruction in a patient with a history of Roux-en-Y gastric bypass.
Soru 3232Soru →

A community health center is initiating a quality improvement protocol to address gaps in age-appropriate and risk-appropriate preventive services. Based on current United States Preventive Services Task Force (USPSTF) guidelines, match each patient profile with the single most urgently indicated screening intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 52-year-old woman who has never smoked. She had a normal colonoscopy at age 50 and negative cervical cytology with HPV co-testing at age 50. Her last breast imaging was performed at age 49.
A 66-year-old man who has never smoked. He underwent a normal abdominal ultrasound at age 65. His last screening colonoscopy was performed 11 years ago.
A 70-year-old man who is a former smoker with a 40 pack-year history, having quit 8 years ago. He is up to date on all gastrointestinal screening and had a normal abdominal ultrasound at age 65.
A 28-year-old woman presenting at 10 weeks gestation for her initial prenatal visit. She is completely asymptomatic and is up to date on cervical cytology and routine adult immunizations.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 52-year-old woman requires mammography (due for biennial screening), the 66-year-old man requires a colonoscopy (11 years since his last exam), the 70-year-old former smoker requires LDCT (meets age, pack-year, and quit-date criteria), and the 28-year-old pregnant woman requires a urine culture for asymptomatic bacteriuria.
Each patient has exactly one outstanding, guideline-directed preventive screening need based on their demographic and clinical profile. Identifying the correct intervention requires knowing the specific start ages, stop ages, screening intervals, and risk-based modifications (such as smoking history or pregnancy) for USPSTF Grade A and B recommendations.

Adım Adım Çözüm

1
Evaluate the 52-year-old woman's preventive care needs.
She requires bilateral screening mammography.
Her last mammogram was 3 years ago. Current guidelines recommend biennial mammography starting at age 40.
2
Evaluate the 66-year-old man's preventive care needs.
He requires a screening colonoscopy.
His last colonoscopy was 11 years ago, which exceeds the standard 10-year interval for average-risk individuals.
3
Evaluate the 70-year-old man's preventive care needs.
He requires low-dose computed tomography (LDCT) of the chest.
He falls within the 50-80 age range, has at least a 20 pack-year history, and quit within the last 15 years.
4
Evaluate the 28-year-old pregnant woman's preventive care needs.
She requires a urine culture for asymptomatic bacteriuria.
Routine screening for asymptomatic bacteriuria is standard at the first prenatal visit to prevent adverse maternal and fetal outcomes.

Anahtar Kavram

Application of age-appropriate, gender-appropriate, and risk factor-based USPSTF preventive screening guidelines.
Soru 3233Soru →

A 42-year-old woman is evaluated in the clinic for a scheduled 4-week follow-up visit. One month ago, she was diagnosed with latent tuberculosis infection after a positive interferon-gamma release assay during a routine occupational health screening. She was started on a 9-month course of daily isoniazid and pyridoxine. Today, the patient reports perfect adherence to her medication regimen. She feels well and specifically denies fatigue, anorexia, nausea, vomiting, right upper quadrant pain, or dark-colored urine. She has no history of liver disease and takes no other medications. She does not consume alcohol.

Vital signs are within normal limits. Physical examination reveals anicteric sclerae and a soft, non-tender abdomen with no palpable hepatomegaly.

Laboratory studies show:
Alanine aminotransferase (ALT): 115 U/L (Reference: 7–52 U/L)
Aspartate aminotransferase (AST): 98 U/L (Reference: 10–40 U/L)
Alkaline phosphatase: 80 U/L (Reference: 40–120 U/L)
Total bilirubin: 0.9 mg/dL (Reference: 0.1–1.2 mg/dL)

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Continue the current medication regimen and repeat liver function tests in 2 to 4 weeks

Cevap

Continue the current medication regimen and repeat liver function tests in 2 to 4 weeks
The correct answer is to continue the current medication regimen and repeat liver function tests. Isoniazid commonly causes a mild, self-limited asymptomatic elevation in aminotransferases (transaminitis) in up to 20% of patients. Clinical guidelines dictate that isoniazid should only be discontinued if aminotransferase levels exceed 5 times the upper limit of normal (ULN) in an asymptomatic patient, or if they exceed 3 times the ULN in a patient experiencing symptoms of hepatotoxicity (e.g., fatigue, nausea, abdominal pain, jaundice). Because this patient is completely asymptomatic and her transaminase levels are less than 3 times the ULN, continuing the medication and providing close laboratory monitoring is the standard of care.

Adım Adım Çözüm

1
Evaluate the patient's clinical presentation and medication history.
The patient is asymptomatic and taking isoniazid for latent tuberculosis infection.
Identifying symptoms of hepatotoxicity is critical for determining the correct threshold for drug discontinuation.
2
Analyze the laboratory results against standard reference ranges.
ALT is approximately 2.2 times the upper limit of normal (ULN), and AST is approximately 2.45 times the ULN. Bilirubin and alkaline phosphatase are normal.
Calculating the magnitude of transaminase elevation directs the application of drug toxicity management guidelines.
3
Apply established guidelines for isoniazid-induced hepatotoxicity.
The criteria to stop isoniazid (elevation > 5x ULN if asymptomatic, or > 3x ULN if symptomatic) are not met.
Since the patient is asymptomatic and elevations are mild (< 3x ULN), the standard of care is to continue the medication and monitor.

Anahtar Kavram

Management of isoniazid-induced hepatotoxicity involves continuing the drug and monitoring if transaminases are elevated but remain less than 5 times the upper limit of normal in asymptomatic patients, or less than 3 times the upper limit of normal in symptomatic patients.
Tahmini Süre:1m 30s
Soru 3234Soru →

A 62-year-old man is recovering on the general medical floor after a three-week hospitalization for severe sepsis secondary to ascending cholangitis. He initially required vasopressor support and mechanical ventilation but is now hemodynamically stable, afebrile, and breathing comfortably on room air. Due to significant intensive care unit-acquired weakness, he cannot perform basic activities of daily living independently. The primary internal medicine team determines that he requires transfer to a skilled nursing facility (SNF) for comprehensive physical and occupational therapy prior to returning home.

Arrange the following essential steps of this care transition process in the most appropriate chronological sequence to ensure patient safety and minimize the risk of readmission.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Document medical stability and specific needs, followed by collaborating to secure authorization and a bed, then performing final medication reconciliation and transfer orders, and finally conducting a structured verbal handoff while transmitting the discharge summary.
Safe and effective care transitions require a standardized, sequential approach to minimize errors. The process must begin with the physician establishing medical readiness and documenting specific post-acute needs. This clinical documentation is strictly required by case management to secure insurance authorization and confirm bed placement at an appropriate facility. Only after the specific destination is confirmed should the final medication reconciliation and transfer orders be generated, ensuring the regimen is accurate and actionable for that specific SNF. Finally, a structured verbal handoff and the transmission of the written discharge summary occur just prior to physical transfer to ensure the receiving team has the most up-to-date, finalized information.

Adım Adım Çözüm

1
Determine readiness and specific needs.
The physician documents that the patient is medically stable but requires SNF-level physical therapy for ICU-acquired weakness.
Clear clinical documentation is the prerequisite for initiating the disposition planning process.
2
Secure facility placement and authorization.
Case management uses the documentation to obtain payer authorization and reserves a bed at an appropriate SNF.
Transfer orders cannot be finalized until a specific receiving destination is confirmed and authorized.
3
Finalize the medical transition plan.
The physician performs medication reconciliation, stopping acute hospital medications (e.g., DVT prophylaxis injections if transitioning to oral) and writes the formal transfer orders.
The receiving facility requires an accurate, finalized set of orders to safely admit the patient and administer medications immediately upon arrival.
4
Execute the clinical handoff.
The primary team provides a structured verbal report to the SNF staff and transmits the comprehensive discharge summary.
Direct communication of the finalized plan prevents continuity of care errors during the vulnerable transition period.

Anahtar Kavram

Standardized Care Transitions and Disposition Planning
Tahmini Süre:1m 15s
Soru 3235Soru →

A 71-year-old man presents to the primary care clinic reporting intense pain and swelling in his right big toe that began abruptly overnight. He states the pain is so severe that he cannot bear weight on his foot or tolerate the touch of a bedsheet. His medical history is significant for ischemic cardiomyopathy with a left ventricular ejection fraction of 30%30\%, stage 4 chronic kidney disease with a baseline estimated glomerular filtration rate of 24 mL/min/1.73 m224 \text{ mL/min/1.73 m}^2, and a hospitalized episode of bleeding peptic ulcer disease three years ago. His current daily medications include carvedilol, sacubitril-valsartan, and low-dose aspirin. Vital signs are temperature 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure 118/76 mmHg118/76\text{ mmHg}, and heart rate 78/min78\text{/min}. Physical examination reveals a markedly erythematous, warm, swollen, and exquisitely tender first metatarsophalangeal joint on the right foot. The remainder of the joint examination is unremarkable. Which of the following is the most appropriate initial pharmacologic intervention for this patient's acute joint pain?

Cevabı ve açıklamayı göster

Cevap: Intra-articular triamcinolone

Cevap

Intra-articular triamcinolone is the most appropriate initial therapy because it provides targeted relief for a monoarticular flare while bypassing the severe systemic risks associated with other agents in a patient with chronic kidney disease, heart failure, and prior peptic ulcer disease.
Intra-articular glucocorticoid injection (e.g., triamcinolone) is the safest and most effective treatment for an acute gout flare localized to 1 or 2 easily accessible joints (such as the first metatarsophalangeal joint) in patients with multiple medical comorbidities. This patient has stage 4 chronic kidney disease, severe heart failure with reduced ejection fraction, and a history of peptic ulcer disease. These conditions present absolute or severe relative contraindications to all first-line systemic therapies for acute gout. Local administration provides rapid anti-inflammatory action within the joint space while minimizing systemic absorption, thereby avoiding nephrotoxicity, fluid retention, and gastrointestinal irritation.

Adım Adım Çözüm

1
Diagnose the acute condition based on the clinical presentation.
The patient has acute monoarticular arthritis of the first metatarsophalangeal joint (podagra), which is classic for an acute gout flare.
Establishing the acute problem is required before selecting pharmacotherapy.
2
Review the patient's medical history for contraindications to standard gout therapies.
The patient has stage 4 chronic kidney disease, ischemic cardiomyopathy with a severely reduced ejection fraction, and a history of peptic ulcer bleeding.
Gout medications have strict contraindications that are frequently tested. Comorbidities dictate the safe treatment path.
3
Evaluate the safety profile of each pharmacological option against the identified comorbidities.
NSAIDs and colchicine are unsafe due to renal impairment and bleeding risk. Systemic steroids are unsafe due to the severe heart failure. Intra-articular steroids remain the only safe option.
To select the single best intervention by process of elimination.

Anahtar Kavram

Management of acute gout in patients with multiple comorbidities often requires localized therapy (intra-articular glucocorticoids) to avoid the systemic contraindications of NSAIDs, colchicine, and oral glucocorticoids.
Tahmini Süre:1m 15s
Soru 3236Soru →

A 62-year-old woman is brought to the emergency department after her family noticed sudden-onset difficulty speaking and right-sided facial droop that began 45 minutes ago. Her medical history includes hypertension and type 2 diabetes mellitus. She is not taking any anticoagulant medications. Vital signs show a blood pressure of 165/90 mm Hg, heart rate of 82/min, and respiratory rate of 16/min. Neurological examination reveals expressive aphasia, right-sided facial droop, and right upper extremity weakness. The physician prepares to evaluate the patient for intravenous thrombolysis. Which of the following diagnostic tests MUST be obtained and reviewed prior to the administration of intravenous alteplase? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Non-contrast computed tomography of the head; Point-of-care blood glucose measurement

Cevap

The only tests required prior to administering intravenous alteplase are a non-contrast computed tomography of the head and a point-of-care blood glucose measurement.
The administration of intravenous alteplase (tPA) for acute ischemic stroke is highly time-sensitive. According to current American Heart Association/American Stroke Association (AHA/ASA) guidelines, the only two diagnostic tests that are strictly required prior to initiating tPA in a standard patient are a non-contrast CT scan of the head (to rapidly rule out intracranial hemorrhage, an absolute contraindication) and a point-of-care blood glucose measurement (to rule out hypoglycemia, a common stroke mimic).

Adım Adım Çözüm

1
Identify the patient's clinical presentation and suspected diagnosis.
The patient is presenting within the 4.5-hour therapeutic window with signs of an acute ischemic stroke.
Determining the time of symptom onset and clinical presentation is necessary to evaluate candidacy for intravenous thrombolysis.
2
Determine the mandatory diagnostic prerequisites for intravenous thrombolysis.
Guidelines mandate ruling out intracranial hemorrhage and hypoglycemia.
Alteplase is contraindicated in hemorrhagic stroke, and hypoglycemia can perfectly mimic stroke symptoms (stroke mimic) but requires completely different treatment.
3
Select the specific tests that fulfill these prerequisites without unnecessarily delaying treatment.
Non-contrast CT of the head and point-of-care blood glucose measurement are selected.
Other tests, while useful for overall management, should not delay the time-sensitive administration of alteplase in a patient without specific risk factors (e.g., current anticoagulant use).

Anahtar Kavram

In patients with suspected acute ischemic stroke who are candidates for thrombolytic therapy, only a non-contrast head CT (to rule out hemorrhage) and a blood glucose assessment (to rule out hypoglycemia) are strictly required before initiating intravenous alteplase.
Soru 3237Soru →

During a scheduled ambulatory clinic visit, a 5757-year-old woman reports a 33-day history of escalating pain and swelling in her left lower extremity. Her medical history is significant for hypertension, diabetic nephropathy, and morbid obesity. Her current medications include nifedipine, sitagliptin, and subcutaneous insulin detemir. Blood pressure is 142/88142/88 mmHg, pulse is 8282/min, and respirations are 1616/min. Pulse oximetry shows 98%98\% on room air. Physical examination reveals that the left calf is erythematous, warm, and measures 55 cm larger in circumference than the right calf. A compressive duplex ultrasonography reveals an acute, noncompressible thrombus in the left popliteal vein. Laboratory studies show:

Hemoglobin: 11.811.8 g/dL
Platelet count: 230,000230,000/mm 3^3
Serum creatinine: 3.13.1 mg/dL
Estimated glomerular filtration rate (eGFR): 1919 mL/min/1.731.73 m 2^2

The patient is hemodynamically stable with normal oxygenation. The physician determines she is an appropriate candidate for immediate outpatient management of her deep vein thrombosis.

Which of the following is the most appropriate pharmacologic intervention for this patient?

Cevabı ve açıklamayı göster

Cevap: Oral apixaban

Cevap

Oral apixaban is the correct choice because it is safe and approved for use in severe renal impairment and allows for outpatient treatment without routine monitoring.
Oral apixaban is the most appropriate pharmacologic intervention for this patient. She requires immediate anticoagulation for an acute deep vein thrombosis in an outpatient setting. However, her severe chronic kidney disease (eGFR 1919 mL/min/1.731.73 m 2^2) limits her therapeutic options. Apixaban is primarily metabolized by the liver and is FDA-approved and considered safe for patients with severe renal impairment (including end-stage renal disease on dialysis). It provides effective anticoagulation without the need for parenteral bridging or routine coagulation monitoring.

Adım Adım Çözüm

1
Diagnose the acute condition and determine the appropriate treatment setting.
The patient has an acute left lower extremity deep vein thrombosis. Being hemodynamically stable, she is a candidate for outpatient anticoagulation.
Initial stabilization and triage guide the choice of inpatient versus outpatient pharmacologic regimens.
2
Evaluate patient-specific contraindications to standard therapies.
The patient has severe chronic kidney disease with an eGFR of 1919 mL/min/1.731.73 m 2^2.
Renal function strictly dictates the safety, dosing, and selection of various anticoagulant medications.
3
Select the optimal anticoagulant based on the renal profile and outpatient setting.
Oral apixaban is selected.
Apixaban undergoes minimal renal clearance compared to other direct oral anticoagulants and is safe in severe renal impairment (eGFR <25< 25 mL/min/1.731.73 m 2^2). It requires no injection bridging or laboratory monitoring.

Anahtar Kavram

Safe selection of oral anticoagulants in the setting of acute deep vein thrombosis and severe chronic kidney disease.
Soru 3238Soru →

A 55-year-old man develops abrupt right-sided chest pain and dyspnea while recovering on the surgical ward. He underwent a partial colectomy for perforated diverticulitis 77 days ago. His postoperative recovery was complicated by severe sepsis and ischemic acute tubular necrosis, for which he currently requires hemodialysis every other day. Since the day of surgery, he has been receiving twice-daily subcutaneous injections of unfractionated heparin for deep vein thrombosis prophylaxis.

Current vital signs include a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure of 110/70 mm Hg110/70\text{ mm Hg}, heart rate of 118/min118/\text{min}, and respiratory rate of 24/min24/\text{min}. Pulse oximetry shows 92%92\% on 4 L/min4\text{ L/min} supplemental oxygen via nasal cannula.

A CT pulmonary angiogram confirms an acute segmental pulmonary embolism in the right lower lobe.

Today's laboratory results show:
Hemoglobin: 9.8 g/dL9.8\text{ g/dL}
Platelet count: 48,000/mm348,000/\text{mm}^3 (down from 260,000/mm3260,000/\text{mm}^3 on admission)
Blood urea nitrogen: 52 mg/dL52\text{ mg/dL}
Serum creatinine: 5.1 mg/dL5.1\text{ mg/dL}

The surgical team suspects heparin-induced thrombocytopenia (HIT). In addition to immediately discontinuing all heparin products, which of the following is the most appropriate pharmacologic intervention?

Cevabı ve açıklamayı göster

Cevap: Initiate intravenous argatroban

Cevap

The most appropriate pharmacologic intervention is to initiate intravenous argatroban, as it provides necessary non-heparin anticoagulation and is safe to use in patients with severe renal impairment.
The correct answer is to initiate intravenous argatroban. This patient has developed a new pulmonary embolism and a significant drop in platelet count (greater than 50%) exactly 7 days after starting unfractionated heparin. This clinical picture is highly suspicious for heparin-induced thrombocytopenia (HIT) complicated by active thrombosis. The immediate management of HIT requires the cessation of all heparin-containing products and the rapid initiation of an alternative, non-heparin systemic anticoagulant to manage the hypercoagulable state. Because this patient has severe acute kidney injury requiring hemodialysis, the preferred agent is argatroban. Argatroban is a direct thrombin inhibitor that is hepatically metabolized, making it safe to use in patients with severe renal impairment without the need for significant dose adjustments.

Adım Adım Çözüm

1
Recognize the clinical presentation of heparin-induced thrombocytopenia (HIT).
The patient has a new pulmonary embolism and a platelet count drop of greater than 50% occurring 7 days after unfractionated heparin exposure, yielding a high 4T score for HIT.
Accurate diagnosis is required to guide the critical decision to stop all current heparin therapy.
2
Determine the immediate management goals for HIT complicated by thrombosis (HITT).
All heparin-containing products must be stopped, and a non-heparin systemic anticoagulant must be initiated immediately.
Despite profound thrombocytopenia, HIT is a severely prothrombotic state, and the new pulmonary embolism requires acute treatment.
3
Evaluate the patient's comorbidities to select the safest non-heparin anticoagulant.
The patient has severe acute kidney injury requiring hemodialysis. Argatroban is hepatically metabolized, whereas alternatives like fondaparinux are renally cleared.
Choosing a renally cleared drug in this patient would lead to toxic accumulation and severe bleeding.
4
Select the final optimal pharmacologic intervention.
Intravenous argatroban is chosen.
It fulfills the requirement for a non-heparin anticoagulant while remaining pharmacokinetically safe in the setting of end-stage renal disease or severe acute kidney injury.

Anahtar Kavram

In suspected heparin-induced thrombocytopenia (HIT), all heparin must be discontinued and a non-heparin anticoagulant started. Argatroban, a direct thrombin inhibitor, undergoes hepatic metabolism and is the preferred agent for patients with concurrent severe renal impairment.
Soru 3239Soru →

Emergency medical services arrive with an elderly female patient, aged 7474 years, complaining of an abrupt onset of excruciating left lower extremity pain that started 44 hours prior to arrival. Her medical history is significant for hypertension, type 22 diabetes mellitus, and paroxysmal atrial fibrillation. She admits she stopped taking her prescribed apixaban two weeks ago due to financial difficulties.

On physical examination, the patient is in obvious distress. Her temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), heart rate is 118/min118/\text{min} and irregular, blood pressure is 145/88 mmHg145/88\text{ mmHg}, and respiratory rate is 18/min18/\text{min}. Evaluation of the left lower extremity reveals it is pale, cold to the touch, and exhibits mottled skin distal to the knee. The patient reports profound numbness over the dorsum of the foot and is completely unable to dorsiflex her toes. Palpation of the left femoral pulse is normal, but the popliteal, dorsalis pedis, and posterior tibial pulses are absent. Bedside continuous-wave Doppler evaluation demonstrates absent arterial signals over the distal left leg, while venous signals remain audible.

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous heparin administration and emergent open surgical embolectomy

Cevap

The correct answer is the administration of intravenous heparin followed by emergent open surgical embolectomy.
The patient has acute limb ischemia (ALI), classified as Rutherford Category IIb (immediately threatened). This is evidenced by sensory loss, a motor deficit (inability to dorsiflex), and the absence of arterial Doppler signals with preserved venous flow. In a patient with atrial fibrillation, this presentation is highly suspicious for an arterial embolus. The definitive management for Rutherford IIb ALI is immediate systemic anticoagulation (intravenous heparin) followed by emergent surgical revascularization, typically via open surgical embolectomy, to rapidly restore perfusion before irreversible neuromuscular damage occurs.

Adım Adım Çözüm

1
Identify the clinical syndrome from the patient's presentation.
The patient has Acute Limb Ischemia (ALI), presenting with the classic signs: pain, pallor, pulselessness, paresthesia, and paralysis (the '5 Ps').
Recognizing the syndrome dictates the urgency of the condition and frames the severity assessment.
2
Classify the severity of the ischemia using the Rutherford criteria based on physical exam findings.
The presence of rest pain, sensory loss beyond the toes, and a motor deficit (inability to dorsiflex), combined with inaudible arterial but audible venous Doppler signals, places this in Category IIb (immediately threatened).
The Rutherford category directly dictates the procedural intervention required. Category IIb specifically delineates a short window for limb salvage.
3
Determine the likely etiology of the ischemia.
The abrupt onset of symptoms in an elderly patient with noncompliant atrial fibrillation strongly points to an arterial thromboembolism.
Embolic occlusions in otherwise healthy vessels are highly amenable to rapid mechanical extraction.
4
Select the appropriate surgical/procedural intervention.
Category IIb ALI requires immediate revascularization. Open surgical embolectomy (e.g., using a Fogarty catheter) is the fastest and most appropriate definitive management.
Alternative therapies like catheter-directed thrombolysis act too slowly, and delaying for advanced imaging (CTA) increases the risk of irreversible necrosis.

Anahtar Kavram

Management of Acute Limb Ischemia (Rutherford Category IIb)
Soru 3240Soru →

A retired construction worker, 68 years of age, is evaluated in the critical care resuscitation bay shortly after experiencing a sudden, excruciating pain between his shoulder blades that he describes as "ripping." He has a history of poorly controlled hypertension and tobacco use. Vital signs reveal a heart rate of 122/min, a respiratory rate of 22/min, and a blood pressure of 78/40 mm Hg in the right arm. On physical examination, the patient is visibly diaphoretic, pale, and lethargic. Cardiopulmonary auscultation reveals a new, faint early decrescendo diastolic murmur at the right upper sternal border. The lungs are clear to auscultation bilaterally. Electrocardiography demonstrates sinus tachycardia with non-specific ST-segment changes. Intravenous fluid resuscitation is immediately initiated via two large-bore peripheral catheters. Which of the following is the most appropriate next step in the diagnostic workup?

Cevabı ve açıklamayı göster

Cevap: Transesophageal echocardiography

Cevap

Transesophageal echocardiography
This patient's presentation of sudden-onset, 'ripping' back pain combined with a new diastolic decrescendo murmur (indicating acute aortic regurgitation) is highly suspicious for an acute ascending aortic dissection (Stanford type A). The patient is in hemodynamic shock, which in this context can result from aortic rupture, cardiac tamponade, or acute severe aortic valve incompetence. When selecting the next step in the diagnostic workup for a suspected aortic dissection, the patient's hemodynamic stability is the most critical deciding factor. For hemodynamically unstable patients, transesophageal echocardiography is the most appropriate next step. It provides excellent visualization of the ascending aorta and aortic valve, boasts high sensitivity and specificity, and crucially, can be performed rapidly at the bedside or in the operating room. This prevents the dangerous transport of an unstable patient away from the resuscitation area.

Adım Adım Çözüm

1
Identify the primary clinical syndrome based on the presentation.
Sudden, tearing back pain with a new decrescendo diastolic murmur (aortic regurgitation) strongly suggests an acute ascending aortic dissection.
Recognizing the classic triad of tearing pain, pulse/blood pressure differentials, and widening mediastinum or new murmur narrows the differential diagnosis.
2
Assess the patient's hemodynamic stability.
The patient is hypotensive, tachycardic, diaphoretic, and lethargic, indicating hemodynamic instability and shock.
Hemodynamic status dictates whether the patient can be safely transported for imaging or if bedside imaging is mandatory.
3
Select the appropriate diagnostic imaging modality.
Transesophageal echocardiography is chosen.
It offers high sensitivity and specificity for aortic dissection and can be performed at the bedside in the emergency department or operating room, maintaining patient safety.

Anahtar Kavram

In hemodynamically unstable patients with suspected acute aortic dissection, bedside transesophageal echocardiography (TEE) is the diagnostic imaging modality of choice to avoid the risks of transporting an unstable patient to the radiology suite.

Alternatif Yöntem

In some specialized trauma centers with 'hybrid' operating rooms, the patient might be taken directly to the OR where both resuscitation and advanced imaging (like intraoperative TEE or portable CT) can occur simultaneously.
Tahmini Süre:1m 30s
ÖncekiSayfa 162 / 237Sonraki